Global Nutrigenomic sales reached approximately USD 594.3 million at the end of 2024. Forecasts suggest the market will achieve a 14.7% compound annual growth rate (CAGR) and exceed USD 2,342.1 million in value by 2034.
The current global food and drinks market, especially personalized nutrition market, is in the process of receiving unprecedented transformation due to the integration of profound gene science progress and people’s rising needs of individual health management. This one is revolutionising how people look at nutrition and fitness by combining devised genetic profiles to design meals, nutraceuticals, and functional foods.
Some of the leading firm at the frontline of this transition are Viome, 23andMe, Nestlé Health Science, Nutrigenomix, and DNAFit. These are companies which are establishing solutions that go across the health needs spectrum, from enhanced uptake of nutrients to managing chronic conditions.
Several forces are at work in determining the future paths of this emerging industry. New diseases that are defined as life style diseases, including diabetes and cardiovascular diseases, make consumer more proactive with personal health management.
During the last decade, progressive innovations in the fields of genetics, DNA matching, and microbiome science have further improved the precision and availability of individual health solutions. Moreover, the growth of information regarding the consuming patterns’ impact on maintainable health has made the customer eager for finer and evidence-based nutrition corrections.
However, the following part of the presented research analysis reveals that this sector has challenges that impact its adoption and growth. Despite all these benefits, costs incurred for genetic testing and tailored approaches still remain elevated hence affecting the inclusion of more population.
The same ethical concerns about the use and storage of such data make the consumers hesitant about the products. Also, there is a desire for additional studies for such products, which show their effectiveness to be deeper and more comprehensive.
| Attributes | Description |
|---|---|
| Estimated Global Industry Size (2024E) | USD 594.3 million |
| Projected Global Industry Value (2034F) | USD 2,342.1 million |
| Value-based CAGR (2024 to 2034) | 14.7% |
In a bid to widen their stake and improve product efficiency, corporate organizations are granting immense capital towards understanding and development to make their products more affordable. Current partnerships among geneticists, nutritionists, and medical workers are also increasing that help in developing more accurate and effective ones.
Current approaches to marketing focus on establishing trusting relations with customers, explaining the need for data collection for the public good and reaping the efficiencies of individualized health promotion. Also, organisations are implementing the subscription-based service delivery system, and combining several services to enhance convenience and customer loyalty.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2023) and current year (2024) for the global industry. This analysis reveals crucial shifts in market performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 2023 | 14.2% (2023 to 2033) |
| H2 2023 | 14.5% (2023 to 2033) |
| H1 2024 | 14.6% (2024 to 2034) |
| H2 2024 | 14.8% (2024 to 2034) |
The global industry's predicted compound annual growth rate (CAGR) over a semi-annual period from 2024 to 2034 is shown in the above table. The business is anticipated to grow at a CAGR of 14.2% in the first half (H1) of 2023 and then slightly faster at 14.5% in the second half (H2) of the same year.
The CAGR is anticipated to increase somewhat to 14.6% in the first half of 2024 and continues to grow at 14.8% in the second half. The industry saw a decline of 35 basis points in the first half (H1 2024) and an increase of 46 basis points in the second half (H2 2024).
Personalized Nutrition Solutions: Tailoring Diets to Individual Genetics
The trend toward individualized nutrition and supplementation is redefining the weight loss and general improvement sector. Businesspersons are using genetic information to develop meal plans tailored towards each person. This approach entails a procedure of testing a person for his/her DNA in order determine his/her genetics on metabolism, intolerances, and health risks.
This way, organizations can advise on a diet appropriate to minimize health risks of heritable diseases including diabetes or heart complications. For instance, Nutrigenomic provides nutrition recommendations based upon the analysis of genetic data; therefore, healthcare employees can establish successful dieting. This trend is growing due to consumers’ growing interest in preventive and personalized health solutions as compared to boilerplate guidance.
Integration of Advanced Technologies in Health Assessments
Advances in technology are changing the ways genetic and nutritive profiling data is processed in order to provide a very accurate health status check. AI and particularly, ML help to interpret intricate genetic and metabolic information to obtain valuable dietary recommendations. Several firms have teamed up with artificial intelligence to go further in understanding the human body and particularly the gut flora: Viome offers clients an analysis of the data and suggests a modification of the diet to improve their health.
These technologies allow for best-practice complimenting dynamic, real-time assessments better in tune with an individual’s current state of health an or well-being. The processes of automation and data modelling bring more accuracy into results, so individual health plans will be more accurate and helpful. Moreover, wearable technology and apps usually enhance these solutions because users can track results and get ongoing guidance.
Expansion of At-Home Genetic Testing Kits
Thanks to home testing, genetic health assessments are now within the reach of many individuals who never thought of them before. These kits enable one to collect samples of DNA and receive a comprehensive analysis of how genes affect his/her diet and associated health complications. bands such as DNAfit and 23andMe have leveraged on this culture to present elaborate testing solutions that depict metabolism, ingestion, and even nutritional custom and fitness preconditions.
This transition from office to home-based practice also marginalize the role of consumers in managing choices of health in their own unique ways. Furthermore, most testing companies provide specific dietary and lifestyle guidelines that align with one’s genes and make it easy to transition from testing to implementation. These products reflect the trend to self-directed management of health that is now popular among the consumers.
Development of Functional Foods Targeting Genetic Profiles
Food products with recommended sets of nutrients that address concerns of an individual based on his/her genes are a fascinating area of convergence of food science and molecular biology. These products are created to have a range of health effects by addressing certain genes linked to such issues as inflammation, heart status, or metabolism.
This nutritional science is carried out by firms such as Metagenics which offers individual foods and nutrient supplements, which are based on these genetic results to supply nutrients that may be missing in an individual’s body or to boost some function of the human body.
For instance, a manipal person suffering from low genetic level of omega-3 may be benefited through once planned diet from omega-3 enriched foods. Not only does it enhance the process of achieving positive health outcomes, but it also changes how consumers approach the food they consume, from more general and associated notions of improvement to directly stated effectiveness.
Emphasis on Gut Health and Microbiome Analysis
Taking care of the gut has become one of the biggest trends for nutritionist companies seeking to establish new layers of the microbiome for improving their dietary solutions. The human body contains billions of bacteria living in a part of the digestive system known as the gut microbiome. Technological advancements in this area include conducting microbial census to determine dysbiosis and prospect foods or supplements that rebalance the gut.
This trend is driven by corporations such as Viome where they conduct microbiome health tests to established the connection between gut flora and diseases such as inflammation, nutrient absorption and even mental health.
These suggestions may direct patients to consume prebiotic products or take probiotics or make some sort of dietary change with relation to the beneficial functioning of the stomach. This focus on the gut shows there is increased societal sensitivity to the complex interactions between nutrition, microbe inhabitants and chronic wellbeing.
Collaboration Between Nutrition and Genetic Research
This molecular-genetic approach in conjunction with the nutritional sciences is rapidly progressing the development of individualized medicine. Through a research proposition from the scientific community, food industries and health care, technologically advanced products that meet health requirements are being developed. For instance, Nestlé Health Science has heavily employed gene information in their nutritional product portfolios to close the research to customer innovation gap.
Such projects might bring together specialists from genetic aspect, information technology specialization, and food industry specialization to work jointly. Partnerships help a process to be completed at a faster pace as evidenced by the fact that they introduced concepts such as customized supplements or functional foods on to the market.
The business landcape has been steadily growing from the year 2019 and it’s due to the rising absorptions on individualized nutrition and the improvement in the technologies to make cheaper genetic tests available. There is projected sales approximately 594.3 million by 2024. However, it is envisaged to gain the momentum in the industry where the industry is predicted to grow at 14.7% CAGR in the forecast period from 2024 to 2034.
Future trends of such growth will depend on improvements of genomic analysis, adoption of nutrigenomics into the mainstream health care sector, and increased public health acceptance of purchased personalized diet plans.
Sphere barriers may include the following: Regulatory concerns, data privacy concerns, low clinical.one could also classify them as market barriers as these factors may deter sector participants from engaging in dal [nutrigenomic tests]. However, the longer-term positions the global nutrigenomics industry for steady and progressive growth.
The industry is characterized by a two-tier structure, which includes both organized and unorganized players. Leading companies such as DSM, BASF SE, Danone S.A., Unilever plc, Genova Diagnostics, Nutrigenomix Inc., Metagenics, Inc., GX Sciences Inc and others some players dominate the organized segment that accounts for 40% of sales in the industry.
Multinational corporations (MNCs) that have target segment revenue greater than 5 million USD belong to these groupings and they maintain their arena presence in this way because they have large volumes of production capacities, high-tech infrastructure and various products.
These well-regulated players have strict distribution networks and can be found in every corner of the world thereby; resulting to huge penetration globally. Their modernized research labs on the other hand enhance innovations enabling them to introduce a range of nutrigenomics with regard to changing trends among health aware consumers who are conscious about their diet.
On the contrary, local participants with target segment revenue below 5 million USD form the unorganized part that contributes up to 60% of total sales within this category. These smaller companies may lack global coverage but are vital for specific areas. Working in niche community allows them offer particular goods fitted for diverse domestic preferences or specialized dietary needs.
In many cases, these entities adjust quickly according to fads in consumer tastes which results into unique and exceptional product mix. This makes sure that there is dynamism as well as competitiveness within industry due to existence of both big and small firms.
This variety brings on board multiple developments along with a wide range of options being made available satisfying different customers across all regions worldwide. This means that the industry has good prospects given its innovative nature coupled with growing trend towards healthier alternatives.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The following table shows the estimated growth rates of the significant three geographies sales. USA, Germany and Australia are set to exhibit high consumption, recording CAGRs of 9.3%, 10.9%, and 12.5% respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 9.3% |
| Germany | 10.9% |
| Australia | 12.5% |
Today, at-home DNA testing kits are a common occurrence in the United States, which has changed consumer’s view on health and nutrition considerably. Organizations such as 23andMe and Viome have made the genetic testing easy, and more individuals can get it. They enable the accumulation of samples at the comfort of one’s home and get detailed results for the carrier statuses of nutrient uptake efficiency, food intolerances, and metabolism.
They have been adopted through convenience as well as the cheap prices which make them easily accessible. Furthermore, most of these reports include precaution on what to eat in the next day’s/weeks and exercise suggestions, giving every person a feeling that they have the power to change. The appeal can be attributed to the transition from conventional nutrition guidance to that of personalised nutrition based on the DNA.
The next focus in the Germany is identified a combination of gene-shopping with continuous improvement of fitness and lifestyle. Leading ones such as DNAFit are leading the way, providing services of which help to identify the best exercises and diet plans based on an individual’s DNA. These solutions do not stop at the question of nutrition: Endurance, regeneration and the effectiveness of muscle building are determined supported by Genetic data.
This is well-liked by the soccer-mad health-oriented people of Germany who look for a proven science to enhance their performance. This is because consumers value the accuracy incorporated in such services, which makes their health goals easy to accomplish, and not by guess-work. Substantial technological advancement and the government support to innovative healthcare technologies together with increasing focus on preventive healthcare have continued to drive this situation.
In Australia, there is functional foods that have the attributes of human genetic types; this new worth is changing the model for disease and eating plan. Current trends are curated by companies like Cell-Logic by formulating nutraceuticals and functional food Innovation to cater for genotypes such as inflammation, metabolism or nutrient deficiencies. People of Australia, who have quite a healthy attitude towards themselves and their lives as well, have immediately welcomed this scientifically backed approach.
These foods do not only satisfy the actual human necessities but also provide specific therapeutic effects thus saving a concept known as nutrition as medicine. Altered palates due to the growing sensitivity to gut health have also prompted the uptake of microbiome targeted functional foods including prebiotic and probiotic foods. This has also been further strengthened by Australia’s mature research environment and consumer loyalty to domestic health brands.
| Segment | Nutritional Supplements (Product Type) |
|---|---|
| Value Share (2024) | 36.2% |
Due to the increased consumer interest in customized Nutraceuticals, the market has made them as a popular market among several novelized healthcare products portfolios. These supplements are designed according to a consumer’s gene type; this makes the improvement of specific health aspects easy, quick and effective.
Unlike the regular multivitamins, they are tailored according to the DNA tests which highlight nutrient metabolism rates, possible deficiencies, or risks of inflammation, oxidative stress and other related problems.
It is also important here to stress that the presented concept fits the modern need for the healthy lifestyle consumers who would prefer to get the safe and efficient treatment. The ability to take supplements in very many ways and at desirable points in the day also boosts their desirability even further.
Some of the firms offering tailored health supplements for instance, Nutrigenomix, Metagenics and others are already using modern scientific genomics to come up with supplements that fit each body type most appropriately.
| Segment | Dietary Supplements (End Use Application) |
|---|---|
| Value Share (2024) | 34.7% |
At present, disease prevention is the most emphasized area of application of personalized nutrition, according to the increasing trend of preventive health approach. As consumers and healthcare practitioners become more savvy about the hereditary factors that play a role in diseases and conditions such as diabetes, cardiovascular diseases, and obesity, both groups are prepared to seek out healthcare products and services that reduce health risks before products manifest themselves.
It gets bio informational interpretation for the certain genetic makeup, and according to obtain, receive differentiate diet and other living conditions changes to prevent get the certain health problems. Industry players such as Nutrigenomic and Viome are already piloting this market, with DNA analysis and microbiome testing. These services allow the user to modify the diet, enhance the intake of nutrients and integrate possible loopholes with supplements.
The nutrigenomic products industry mainly driven by increased public awareness on tailored nutrition and the role of genes in influencing health and nutrition. The largest players in global pharma and nutrition are putting a lot of money in innovative research focusing on nutrigenomics products and services. However, as the market progresses the competition between these firms will be stiff.
However, new small specialized firms are also approaching the market with specific nutrigenomic services. The growth in the genomic tech industry and easy availability and increased usage of direct to consumer genetic testing kits are further acting as market drivers.
However, regulatory challenges and data privacy issues may act as headwinds for the industry players for the industry players. In general, the nutrigenomic market still presents large opportunities to firms that will successfully capitalize on the nascent concept of diet customization.
By product type industry has been categorised into Nutrigenomic Testing Kits., Personalized Nutritional Supplements, Functional Foods and Beverages, and others.
Key applications like Food and Beverage processing, dietary supplements, personal care & cosmetics, Others are included in the report.
By distribution channel industry has been categorised into Direct-to-Consumer (DTC) Platforms (e.g., 23andMe, Viome), Pharmacies and Clinics, Online Retailers, Specialized Nutrigenomic Companies
Industry analysis has been carried out in key countries of North America, Latin America, Europe, Middle East and Africa, East Asia, South Asia, and Oceania.
The value of the industry is estimated to reach 594.3 million USD by the end of year 2024.
By 2034, the sales value is expected to be worth USD 2,342.1 million.
The sales increased at a CAGR of around 14.1% over the past half-decade.
Europe is expected to dominate the global consumption.
Some of the key players in manufacturing include DSM, BASF SE, Danone S.A., Unilever plc, Genova Diagnostics, Nutrigenomix Inc., Metagenics, Inc., GX Sciences Inc and few others.
| Estimated Size (2024E) | USD 596.1 million |
|---|---|
| Projected Value (2034F) | USD 1,479.1 million |
| Value-based CAGR (2024 to 2034) | 9.5% |
| Estimated Size (2024E) | USD 917.0 million |
|---|---|
| Projected Value (2034F) | USD 2,054.7 million |
| Value-based CAGR (2024 to 2034) | 8.4% |
Explore Food Technology Insights
View Reports
Nutrigenomic Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
